Consistent with these results, we found decreased concentrations of beclin‐1 and ATG‐5 in the hippocampus and cerebral cortex of the AD group compared to the naive group (Figure 7o; Figure S5O), and the decrease was significant for beclin‐1 in the hippocampus (Figure 7o). This evidence concerns the gene ATG5 and Alzheimer disease.